Internal Med
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



1. Report Shows Shift in Starting Salaries for Physicians
2. Recommendations on the use of 18F-FDG PET in oncology
3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer
4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
5. Rapid correction of low vitamin D status in nursing home residents

Top Ten Searches

etanercept
hypertension
chf
antiphospholipid
fibrosis
mrsa
scid
renal cell
rickets
counterpulsation

Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mitochondrial Dysfunction in Atherosclerosis
Circulation Research, 03/02/07

Nageswara R. Madamanchi, et al. – Increased production of reactive oxygen species in mitochondria, accumulation of mitochondrial DNA damage, and progressive respiratory chain dysfunction are associated with atherosclerosis or cardiomyopathy in human investigations and animal models of oxidative stress


Previous Article Next Article

Today in Atherosclerosis/Lipids...keeping you current

Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study)
The American Journal of Cardiology, 06/22/09

Residual cardiovascular risk in treated hypertension and hyperlipidaemia: The PRIME Study
Journal of Human Hypertension, 06/03/09

Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid sub-study
Breast Cancer Research, 06/18/09

See All of Atherosclerosis/Lipids

Today in Cardiology...keeping you current

Catheter ablation vs. amiodarone plus losartan for prevention of atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation
European Journal of Clinical Investigation, 06/01/09

Valsartan for Prevention of Recurrent Atrial Fibrillation
New England Journal of Medicine, 04/16/09

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): A multicentre, randomised, open-label trial
The Lancet - Early Online Publication, 06/09/09

See All of Cardiology

Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address